Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro

Molecular and Cellular Endocrinology

Volumn 422, Issue , 2016, Pages 103-114

  Casarini, Livio ^a   Riccetti, Laura ^a   De Pascali, Francesco ^a   Nicoli, Alessia ^b   Tagliavini, Simonetta ^c   Trenti, Tommaso ^c   La Sala, Giovanni Battista ^a,b   Simoni, Manuela ^a,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c AUSL Modena   (Italy)

Author keywords

FSH; Granulosa cells; HCG; LH; LHCGR

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE; PROTEIN KINASE B; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; CHORIONIC GONADOTROPIN; CREB1 PROTEIN, HUMAN; FOLLITROPIN; LUTEINIZING HORMONE; STEROID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GRANULOSA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFERTILITY THERAPY; LUTEAL CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; ADULT; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM;

ADULT; APOPTOSIS; CELLS, CULTURED; CHORIONIC GONADOTROPIN; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG SYNERGISM; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; IN VITRO TECHNIQUES; LUTEAL CELLS; LUTEINIZING HORMONE; SIGNAL TRANSDUCTION; STEROIDS;

EID: 84956666390     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.12.008     Document Type: Article

References (107)

1. Aharoni D., Dantes A., Oren M., Amsterdam A. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells. Exp. Cell. Res. 1995, 218(1):271-282.
2. Ahtiainen P., Rulli S., Pakarainen T., Zhang F.P., Poutanen M., Huhtaniemi I. Phenotypic characterisation of mice with exaggerated and missing LH/hCG action. Mol. Cell. Endocrinol. 2007, 260-262:255-263.
3. Altmäe S., Martinez-Conejero J.A., Esteban F.J., Ruiz-Alonso M., Stavreus-Evers A., Horcajadas J.A., Salumets A. MicroRNAs miR-30b, miR-30d, and miR-494 regulate human endometrial receptivity. Reprod. Sci. 2013, 20(3):308-317.
4. Amsterdam A., Gold R.S., Hosokawa K., Yoshida Y., Sasson R., Jung Y., Kotsuji F. Crosstalk among multiple signaling pathways controlling ovarian cell death. Trends Endocrinol. Metab. 1999, 10(7):255-262.
5. Amsterdam A., Hanoch T., Dantes A., Tajima K., Strauss J.F., Seger R. Mechanisms of gonadotropin desensitization. Mol. Cell. Endocrinol. 2002, 187(1-2):69-74.
6. Amsterdam A., Sasson R., Keren-Tal I., Aharoni D., Dantes A., Rimon E., Land A., Cohen T., Dor Y., Hirsh L. Alternative pathways of ovarian apoptosis: death for life. Biochem. Pharmacol. 2003, 66(8):1355-1362.
7. Arey B.J., López F.J. Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications. Rev. Endocr. Metab. Disord. 2011, 12(4):275-288.
8. Ascoli M., Fanelli F., Segaloff D.L. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 2002, 23(2):141-174.
9. Ayoub M.A., Landomiel F., Gallay N., Jégot G., Poupon A., Crépieux P., Reiter E. Assessing gonadotropin receptor function by resonance energy transfer-based assays. Front. Endocrinol. Lausanne 2015, 6:130.
10. Bebia Z., Somers J.P., Liu G., Ihrig L., Shenker A., Zeleznik A.J. Adenovirus-directed expression of functional luteinizing hormone (LH) receptors in undifferentiated rat granulosa cells: evidence for differential signaling through follicle-stimulating hormone and LH receptors. Endocrinology 2001, 142(6):2252-2259.
11. Ben-Ami I., Armon L., Freimann S., Strassburger D., Ron-El R., Amsterdam A. EGF-like growth factors as LH mediators in the human corpus luteum. Hum. Reprod. 2009, 24(1):176-184.
12. Berndt S., Blacher S., Munaut C., Detilleux J., Perrier d'Hauterive S., Huhtaniemi I., Evain-Brion D., Noël A., Fournier T., Foidart J.M. Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-β receptor activation. FASEB J. 2013, 27(4):1309-1321.
13. Berthois Y., Katzenellenbogen J.A., Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. U. S. A. 1986, 83(8):2496-2500.
14. Bonomi M., Busnelli M., Persani L., Vassart G., Costagliola S. Structural differences in the hinge region of the glycoprotein hormone receptors: evidence from the sulfated tyrosine residues. Mol. Endocrinol. 2006, 20(12):3351-3363.
15. Bousfield G.R., Butnev V.Y., Butnev V.Y., Hiromasa Y., Harvey D.J., May J.V. Hypo-glycosylated human follicle-stimulating hormone (FSH(21/18)) is much more active in vitro than fully-glycosylated FSH (FSH(24)). Mol. Cell. Endocrinol. 2014, 382(2):989-997.
16. Breckwoldt M., Selvaraj N., Aharoni D., Barash A., Segal I., Insler V., Amsterdam A. Expression of Ad4-BP/cytochrome P450 side chain cleavage enzyme and induction of cell death in long-term cultures of human granulosa cells. Mol. Hum. Reprod. 1996, 2(6):391-400.
17. Breen S.M., Knox R.V. The impact of dose of FSH (Folltropin) containing LH (Lutropin) on follicular development, estrus and ovulation responses in prepubertal gilts. Anim. Reprod. Sci. 2012, 132(3-4):193-200.
18. Carone D., Caropreso C., Vitti A., Chiappetta R. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols. J. Endocrinol. Investig. 2012, 35(11):996-1002.
19. Casarini L., Pignatti E., Simoni M. Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Rev. Endocr. Metab. Disord. 2011, 12(4):303-321.
20. Casarini L., Lispi M., Longobardi S., Milosa F., La Marca A., Tagliasacchi D., Pignatti E., Simoni M. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS One 2012, 7(10):e46682.
21. Casarini L., Brigante G. The polycystic ovary syndrome evolutionary paradox: a genome-wide association studies-based, in silico, evolutionary explanation. J. Clin. Endocrinol. Metab. 2014, 99(11):E2412-E2420.
22. Casarini L., Moriondo V., Marino M., Adversi F., Capodanno F., Grisolia C., La Marca A., La Sala G.B., Simoni M. FSHR polymorphism p.N680S mediates different responses to FSH in vitro. Mol. Cell. Endocrinol. 2014, 393(1-2):83-91.
23. Cecconi S., Mauro A., Cellini V., Patacchiola F. The role of Akt signalling in the mammalian ovary. Int. J. Dev. Biol. 2012, 56(10-12):809-817.
24. Cervantes D., Crosby C., Xiang Y. Arrestin orchestrates crosstalk between G protein-coupled receptors to modulate the spatiotemporal activation of ERK MAPK. Circ. Res. 2010, 106(1):79-88.
25. Choi J., Smitz J. Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles. Gynecol. Endocrinol. 2014, 30(3):174-181.
26. Cole L.A. Biological functions of hCG and hCG-related molecules. Reprod. Biol. Endocrinol. 2010, 8:102.
27. Cole L.A. Hyperglycosylated hCG and pregnancy failures. J. Reprod. Immunol. 2012, 93(2):119-122.
28. Cole L.A., Butler S.A. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters. J. Reprod. Med. 2008, 53(7):499-512.
29. Conti M. Specificity of the cyclic adenosine 3',5'-monophosphate signal in granulosa cell function. Biol. Reprod. 2002, 67:1653-1661.
30. Craig J., Orisaka M., Wang H., Orisaka S., Thompson W., Zhu C., Kotsuji F., Tsang B.K. Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death. Front. Biosci. 2007, 12:3628-3639.
31. Crochet J.R., Shah A.A., Schomberg D.W., Price T.M. Hyperglycosylated human chorionic gonadotropin does not increase progesterone production by luteinized granulosa cells. J. Clin. Endocrinol. Metab. 2012, 97(9):E1741-E1744.
32. Dain L., Guerrero H., Polak de Fried E., Tesone M. Regulation of the steroidogenic response of cultured human granulosa cells: effects of serum and 25-hydroxycholesterol. Fertil. Steril. 1995, 64(2):335-339.
33. Devaseelan P., Fogarty P.P., Regan L. Human chorionic gonadotrophin for threatened miscarriage. Cochrane Database Syst. Rev. 2010, (5):CD007422.
34. Dean M.K., Higgs C., Smith R.E., Bywater R.P., Snell C.R., Scott P.D., Upton G.J., Howe T.J., Reynolds C.A. Dimerization of G-protein-coupled receptors. J. Med. Chem. 2001, 44(26):4595-4614.
35. Donadeu F.X., Ascoli M. The differential effects of the gonadotropin receptors on aromatase expression in primary cultures of immature rat granulosa cells are highly dependent on the density of receptors expressed and the activation of the inositol phosphate cascade. Endocrinology 2005, 146(9):3907-3916.
36. Fábregues F., Creus M., Casals G., Carmona F., Balasch J. Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol. Gynecol. Endocrinol. 2013, 29(5):430-435.
37. Fares F. The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists. Biochim. Biophys. Acta 2006, 1760(4):560-567.
38. Feng X., Zhang M., Guan R., Segaloff D.L. Heterodimerization between the lutropin and follitropin receptors is associated with an attenuation of hormone-dependent signaling. Endocrinology 2013, 154(10):3925-3930.
39. Fournier T., Guibourdenche J., Evain-Brion D. Review: hCGs: different sources of production, different glycoforms and functions. Placenta 2015, 36(Suppl. 1):S60-S65.
40. Freimann S., Ben-Ami I., Dantes A., Ron-El R., Amsterdam A. EGF-like factor epiregulin and amphiregulin expression is regulated by gonadotropins/cAMP in human ovarian follicular cells. Biochem. Biophys. Res. Commun. 2004, 324(2):829-834.
41. Gabay R., Rozen S., Samokovlisky A., Amor Y., Rosenfeld R., Kohen F., Amsterdam A., Berger P., Ben-Menahem D. The role of the 3' region of mammalian gonadotropin β subunit gene in the luteinizing hormone to chorionic gonadotropin evolution. Mol. Cell. Endocrinol. 2014, 382(2):781-790.
42. Galet C., Ascoli M. The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues. Mol. Endocrinol. 2005, 19(5):1263-1276.
43. Grzesik P., Kreuchwig A., Rutz C., Furkert J., Wiesner B., Schuelein R., Kleinau G., Gromoll J., Krause G. Differences in signal activation by LH and hCG are mediated by the LH/CG receptor's extracellular hinge region. Front. Endocrinol. Lausanne 2015, 6:140.
44. Grzesik P., Teichmann A., Furkert J., Rutz C., Wiesner B., Kleinau G., Schülein R., Gromoll J., Krause G. Differences between lutropin-mediated and choriogonadotropin-mediated receptor activation. FEBS J. 2014, 281(5):1479-1492.
45. Gupta C., Chapekar T., Chhabra Y., Singh P., Sinha S., Luthra K. Differential response to sustained stimulation by hCG & LH on goat ovarian granulosa cells. Indian. J. Med. Res. 2012, 135:331-340.
46. Hanson F.W., Powell J.E., Stevens V.C. Effects of HCG and human pituitary LH on steroid secretion and functional life of the human corpus luteum. J. Clin. Endocrinol. Metab. 1971, 32(2):211-215.
47. Henke A., Gromoll J. New insights into the evolution of chorionic gonadotrophin. Mol. Cell. Endocrinol. 2008, 291(1-2):11-19.
48. Huhtaniemi I., Ahtiainen P., Pakarainen T., Rulli S.B., Zhang F.P., Poutanen M. Genetically modified mouse models in studies of luteinising hormone action. Mol. Cell. Endocrinol. 2006, 252(1-2):126-135.
49. Ji I., Lee C., Song Y., Conn P.M., Ji T.H. Cis- and trans-activation of hormone receptors: the LH receptor. Mol. Endocrinol. 2002, 16(6):1299-1308.
50. Jiang X., Liu H., Chen X., Chen P.H., Fischer D., Sriraman V., Yu H.N., Arkinstall S., He X. Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(31):12491-12496.
51. Jolly P.D., Tisdall D.J., Heath D.A., Lun S., McNatty K.P. Apoptosis in bovine granulosa cells in relation to steroid synthesis, cyclic adenosine 3',5'-monophosphate response to follicle-stimulating hormone and luteinizing hormone, and follicular atresia. Biol. Reprod. 1994, 51(5):934-944.
52. Kanamarlapudi V., Thompson A., Kelly E., López Bernal A. ARF6 activated by the LHCG receptor through the cytohesin family of guanine nucleotide exchange factors mediates the receptor internalization and signaling. J. Biol. Chem. 2012, 287(24):20443-20455.
53. Kawamura K., Cheng Y., Suzuki N., Deguchi M., Sato Y., Takae S., Ho C.H., Kawamura N., Tamura M., Hashimoto S., Sugishita Y., Morimoto Y., Hosoi Y., Yoshioka N., Ishizuka B., Hsueh A.J. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(43):17474-17479.
54. Keren-Tal I., Suh B.S., Dantes A., Lindner S., Oren M., Amsterdam A. Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells. Exp. Cell. Res. 1995, 218(1):283-295.
55. Khan-Sabir N., Beshay V.E., Carr B.R. The Normal Menstrual Cycle and the Control of Ovulation. in: Endotext. Chapter 3 2008, http://www.endotext.org.
56. Koistinen H., Hautala L., Koli K., Stenman U.H. Absence of TGF-β Receptor Activation by Highly Purified hCG Preparations. Mol. Endocrinol. 2015, 29(12):1787-1791.
57. Lee P.S., Buchan A.M., Hsueh A.J., Yuen B.H., Leung P.C. Intracellular calcium mobilization in response to the activation of human wild-type and chimeric gonadotropin receptors. Endocrinology 2002, 143(5):1732-1740.
58. Lehert P., Kolibianakis E.M., Venetis C.A., Schertz J., Saunders H., Arriagada P., Copt S., Tarlatzis B. Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod. Biol. Endocrinol. 2014, 12:17.
59. Liao X.H., Wang Y., Wang N., Yan T.B., Xing W.J., Zheng L., Zhao D.W., Li Y.Q., Liu L.Y., Sun X.G., Hu P., Zhang T.C. Human chorionic gonadotropin decreases human breast cancer cell proliferation and promotes differentiation. IUBMB Life 2014, 66(5):352-360.
60. Lindsey A.M., Channing C.P. Effect of a phosphodiesterase inhibitor, 3-isobutyl 1-methylxanthine, upon the stimulatory effect of human follicle-stimulating hormone and human luteinizing hormone upon cyclic adenosine 3':5'-monophosphate accumulation by porcine granulosa cells. Proc. Soc. Exp. Biol. Med. 1978, 159(2):230-236.
61. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
62. Ludwig M., Westergaard L.G., Diedrich K., Andersen C.Y. Developments in drugs for ovarian stimulation. Best. Pract. Res. Clin. Obstet. Gynaecol. 2003, 17(2):231-247.
63. Mazurkiewicz J.E., Herrick-Davis K., Barroso M., Ulloa-Aguirre A., Lindau-Shepard B., Thomas R.M., Dias J.A. Single-molecule analyses of fully functional fluorescent protein-tagged follitropin receptor reveal homodimerization and specific heterodimerization with lutropin receptor. Biol. Reprod. 2015, 92(4):100.
64. Manna P.R., Dyson M.T., Eubank D.W., Clark B.J., Lalli E., Sassone-Corsi P., Zeleznik A.J., Stocco D.M. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol. Endocrinol. 2002, 16(1):184-199.
65. Matsuda-Minehata F., Inoue N., Goto Y., Manabe N. The regulation of ovarian granulosa cell death by pro- and anti-apoptotic molecules. J. Reprod. Dev. 2006, 52(6):695-705.
66. Matzuk M.M., DeMayo F.J., Hadsell L.A., Kumar T.R. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biol. Reprod. 2003, 69(1):338-346.
67. McNatty K.P., Lun S., Hudson N.L., Forbes S. Effects of follicle stimulating hormone, cholera toxin, pertussis toxin and forskolin on adenosine cyclic 3',5'-monophosphate output by granulosa cells from Booroola ewes with or without the F gene. J. Reprod. Fertil. 1990, 89(2):553-563.
68. Moro F., Scarinci E., Palla C., Romani F., Familiari A., Tropea A., Leoncini E., Lanzone A., Apa R. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT. Hum. Reprod. 2015, 30(1):179-185.
69. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65(1-2):55-63.
70. Müller T., Gromoll J., Simoni M. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J. Clin. Endocrinol. Metab. 2003, 88(5):2242-2249.
71. Musnier A., Blanchot B., Reiter E., Crépieux P. GPCR signalling to the translation machinery. Cell. Signal 2010, 22(5):707-716.
72. Nechamen C.A., Thomas R.M., Dias J.A. APPL1, APPL2, Akt2 and FOXO1a interact with FSHR in a potential signaling complex. Mol. Cell. Endocrinol. 2007, 260-262:93-99.
73. Nordhoff V., Sonntag B., von Tils D., Götte M., Schüring A.N., Gromoll J., Redmann K., Casarini L., Simoni M. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells. Reprod. Biomed. Online 2011, 23(2):196-203.
74. Pakarainen T., Zhang F.P., Nurmi L., Poutanen M., Huhtaniemi I. Knockout of luteinizing hormone receptor abolishes the effects of follicle-stimulating hormone on preovulatory maturation and ovulation of mouse graafian follicles. Mol. Endocrinol. 2005, 19(10):2591-2602.
75. Papaleo E., Vanni V.S., Viganò P., La Marca A., Pagliardini L., Vitrano R., Zanirato M., Marsiglio E., Privitera L., Candiani M. Recombinant LH administration in subsequent cycle after "unexpected" poor response to recombinant FSH monotherapy. Gynecol. Endocrinol. 2014, 30(11):813-816.
76. Patel S.S., Beshay V.E., Escobar J.C., Suzuki T., Carr B.R. Molecular mechanism for repression of 17alpha-hydroxylase expression and androstenedione production in granulosa cells. J. Clin. Endocrinol. Metab. 2009, 94(12):5163-5168.
77. Peltoketo H., Zhang F.P., Rulli S.B. Animal models for aberrations of gonadotropin action. Rev. Endocr. Metab. Disord. 2011, 12(4):245-258.
78. Perez Mayorga M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 2000, 85(9):3365-3369.
79. Pitcher J.A., Tesmer J.J., Freeman J.L., Capel W.D., Stone W.C., Lefkowitz R.J. Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J. Biol. Chem. 1999, 274(49):34531-34534.
80. Prinz H. Hill coefficients, dose-response curves and allosteric mechanisms. J. Chem. Biol. 2010, 3(1):37-44.
81. Razi M.H., Mohseni F., Dehghani Firouzabadi R., Janati S., Yari N., Etebary S. Results from adding recombinant LH for assisted reproductive technology treatment: a randomized control trial. Iran J. Reprod. Med. 2014, 12(2):111-116.
82. Reigstad M.M., Larsen I.K., Myklebust T.Å., Robsahm T.E., Oldereid N.B., Omland A.K., Vangen S., Brinton L.A., Storeng R. Risk of breast cancer following fertility treatment-a registry based cohort study of parous women in Norway. Int. J. Cancer 2015, 136(5):1140-1148.
83. Requena A., Cruz M., Ruiz F.J., García-Velasco J.A. Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin. Reprod. Biol. Endocrinol. 2014, 12:10.
84. Revelli A., Pettinau G., Basso G., Carosso A., Ferrero A., Dallan C., Canosa S., Gennarelli G., Guidetti D., Filippini C., Benedetto C. Controlled ovarian stimulation with recombinant-FSH plus recombinant-LH vs. human menopausal gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population. Reprod. Biol. Endocrinol. 2015, 13:77.
85. Risma K.A., Clay C.M., Nett T.M., Wagner T., Yun J., Nilson J.H. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. U. S. A. 1995, 92(5):1322-1326.
86. Ruvolo G., Bosco L., Pane A., Morici G., Cittadini E., Roccheri M.C. Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil. Steril. 2007, 87(3):542-546.
87. Ryan K.E., Glister C., Lonergan P., Martin F., Knight P.G., Evans A.C. Functional significance of the signal transduction pathways Akt and Erk in ovarian follicles: in vitro and in vivo studies in cattle and sheep. J. Ovarian Res. 2008, 1(1):2.
88. Schaarschmidt J., Huth S., Meier R., Paschke R., Jaeschke H. Influence of the hinge region and its adjacent domains on binding and signaling patterns of the thyrotropin and follitropin receptor. PLoS One 2014, 9(10):e111570.
89. Schrage R., De Min A., Hochheiser K., Kostenis E., Mohr K. Superagonism at G protein-coupled receptors and beyond. Br. J. Pharmacol. 2015, (in press). 10.1111/bph.13278.
90. Segaloff D.L. Regulatory processes governing the cell surface expression of LH and FSH receptors. Subcell. Biochem. 2012, 63:113-129.
91. Segers I., Adriaenssens T., Wathlet S., Smitz J. Gene expression differences induced by equimolar low doses of LH or hCG in combination with FSH in cultured mouse antral follicles. J. Endocrinol. 2012, 215(2):269-280.
92. Shoham Z., Jacobs H.S., Insler V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil. Steril. 1993, 59(6):1153-1161.
93. Soave I., Marci R. Ovarian stimulation in patients in risk of OHSS. Minerva Ginecol. 2014, 66(2):165-178.
94. Society of Obstetricians and Gynaecologists of Canada, Okun N., Sierra S. Pregnancy outcomes after assisted human reproduction. J. Obstet. Gynaecol. Can. 2014, 36(1):64-83.
95. Thomas R.M., Nechamen C.A., Mazurkiewicz J.E., Muda M., Palmer S., Dias J.A. Follice-stimulating hormone receptor forms oligomers and shows evidence of carboxyl-terminal proteolytic processing. Endocrinology 2007, 148(5):1987-1995.
96. Vassart G., Pardo L., Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends. Biochem. Sci. 2004, 29(3):119-126.
97. Wang X.N., Greenwald G.S. Synergistic effects of steroids with FSH on folliculogenesis, steroidogenesis and FSH- and hCG-receptors in hypophysectomized mice. J. Reprod. Fertil. 1993, 99(2):403-413.
98. Weedon-Fekjær M.S., Taskén K. Review: spatiotemporal dynamics of hCG/cAMP signaling and regulation of placental function. Placenta 2012, 33(Suppl. l):S87-S91.
99. Weisman Z., Dirnfeld M., Lissak A., Sorokin Y., Abramovici H. Oral contraceptive pills and follicular fluid hormones in an in vitro fertilization program. Fertil. Steril. 1989, 52(3):451-453.
100. Yamanouchi H., Ishii S. Positive cooperative action of follicle-stimulating hormone on binding of luteinizing hormone to testicular receptors from the bullfrog (Rana catesbeiana). Gen. Comp. Endocrinol. 1990, 78(2):231-241.
101. Yamoto M., Shima K., Nakano R. Gonadotropin receptors in human ovarian follicles and corpora lutea throughout the menstrual cycle. Horm. Res. 1992, 37(Suppl. 1):5-11.
102. Yazici Yilmaz F., Görkemli H., Çolakoğlu M.C., Aktan M., Gezginç K. The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation. Gynecol. Endocrinol 2015, 31(2):141-144.
103. Yong E.L., Baird D.T., Hillier S.G. Mediation of gonadotrophin-stimulated growth and differentiation of human granulosa cells by adenosine-3',5'-monophosphate: one molecule, two messages. Clin. Endocrinol. Oxf. 1992, 37(1):51-58.
104. Yuan W., Greenwald G.S. Luteotropic effects of follicle-stimulating hormone (FSH): I. FSH has in vitro luteotropic and synergistic effects with luteinizing hormone and prolactin on progesterone production by hamster luteal cells during pregnancy. Biol. Reprod. 1994, 51(1):43-49.
105. Zhang M., Ouyang H., Xia G. The signal pathway of gonadotrophins-induced mammalian oocyte meiotic resumption. Mol. Hum. Reprod. 2009, 15(15):399-499.
106. Ziebe S., Lundin K., Janssens R., Helmgaard L., Arce J.C., MERIT (Menotrophin vs Recombinant FSH in vitro Fertilisation Trial) Group Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum. Reprod. 2007, 22(9):2404-2413.
107. Zwain I.H., Amato P. cAMP-induced apoptosis in granulosa cells is associated with up-regulation of P53 and bax and down-regulation of clusterin. Endocr. Res. 2001, 27(1-2):233-249.